- Record: found
- Abstract: not found
- Article: not found
Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolomide in newly diagnosed, MGMT-non-methylated glioblastoma patients.
U Herrlinger, N. Schaefer, J. Steinbach, A. Weyerbrock, P Hau, R. Goldbrunner, JP Steinbach, N Foldvary-Schaefer, P Hau, F Friedrich-Ebert-Stiftung, V Rohde, F Ringel, C Braun-Breton, R Kohnen, B Leutgeb, C Belka, H Urbach, W Stummer, M Glas
2014
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.